BTAI Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

KUPNO 107835 min ago

@ $3.11

Wydano: 14 vas. 2024 @ 20:43

Zwrot: -16.40%

Poprzedni sygnał: vas. 14 - 18:27

Poprzedni sygnał: Sprzedaż

Zwrot: 3.15 %

Live Chart Being Loaded With Signals

Commentary (29 bal. 2024 @ 18:54):

BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology...

Stats
Dzisiejszy wolumen	132 867
Średni wolumen	1.54M
Kapitalizacja rynkowa	96.29M
EPS	$0 ( 2024-03-12 )
Następna data zysków	( $-0.730 ) 2024-06-10
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.420
ATR14	$0.00600 (0.23%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-15	O'neill Vincent	Sell	2 250	Restricted Stock Units
2024-03-15	O'neill Vincent	Buy	2 250	Common Stock
2024-04-04	O'neill Vincent	Sell	165	Common Stock
2024-03-14	O'neill Vincent	Sell	521	Restricted Stock Units
2024-03-14	O'neill Vincent	Buy	521	Common Stock

INSIDER POWER
-8.71
Last 87 transactions
Buy: 187 774 \| Sell: 228 648

Wolumen Korelacja

Długi: -0.01 (neutral)

Krótki: -0.38 (neutral)

Signal:(47.457) Neutral

BioXcel Therapeutics Inc Korelacja

10 Najbardziej pozytywne korelacje
AGNC	0.927
NWL	0.905
BOCH	0.904
PRAX	0.896
YQ	0.896
SLVO	0.894
GRFS	0.893
SHYF	0.891
CASS	0.888
CLPS	0.888

10 Najbardziej negatywne korelacje
CRSA	-0.937
LONE	-0.906
PPBT	-0.903
SNCR	-0.902
TSLA	-0.897
MVBF	-0.882
TLMD	-0.88
EPZM	-0.878
RMRM	-0.876
MTEK	-0.876

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

BioXcel Therapeutics Inc Korelacja - Waluta/Towar

-0.52
( weak negative )

-0.41
( neutral )

0.00
( neutral )

-0.51
( weak negative )

0.66
( moderate )

0.09
( neutral )

BioXcel Therapeutics Inc Finanse

Annual	2023
Przychody:	$1.38M
Zysk brutto:	$-198 000 (-14.35 %)
EPS:	$-6.15

FY	2023
Przychody:	$1.38M
Zysk brutto:	$-198 000 (-14.35 %)
EPS:	$-6.15

FY	2022
Przychody:	$375 000
Zysk brutto:	$355 000 (94.67 %)
EPS:	$-6.13

FY	2021
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$0

Financial Reports:

No articles found.

BioXcel Therapeutics Inc

BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and proprietary machine learning algorithms to identify new therapeutic indices. Its commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults. The company also continues to conduct clinical trials evaluating BXCL501 for the treatment of agitation in Alzheimer's disease patients, and for adjunctive treatment of patients with major depressive disorder, as well as in the community for agitation associated with bipolar disorders and schizophrenia. In addition, it is developing BXCL502 as a potential therapy for chronic agitation in dementia; and BXCL701, an investigational, orally administered, systemic innate immunity activator for the treatment of aggressive forms of prostate cancer and advanced solid tumors that are refractory or treatment naïve to checkpoint inhibitors. The company was incorporated in 2017 and is headquartered in New Haven, Connecticut.